DQ — Deck
Daqo manufactures high-purity polysilicon in China and sells it to solar wafer, cell, and module producers, with profit driven by the spread between polysilicon prices and production cost.
One number decides the stock: above-cost polysilicon sales.
- Q1 went on strike. Daqo produced 43.4k MT and sold 4.5k MT after prices fell below production cost; revenue dropped 88% sequentially to $26.7M.
- Cost is the line. Q1 ASP was $5.96/kg against $5.95/kg total production cost, so a few cents decide whether volume creates cash or inventory.
- June matters. Management expects a midyear cost model and minimum-price guidance; no enforcement means lower utilization and market-price selling.
The balance sheet gives Daqo time; the P&L needs proof.
The bull case starts with survival: liquid assets exceed the $1.3B market cap and financial debt is zero. The bear case starts with usage of that cash: Q1 operating cash flow was -$147.5M while about 39k MT of quarterly production did not turn into sales.
The 2022 boom became a 2026 policy trade.
Before: In FY2022, revenue reached $4.61B and operating margin hit 66.0% as polysilicon prices sat far above cost. Daqo used the boom to build a net-cash balance sheet and expand capacity.
Pivot: By FY2025, revenue fell to $665M, gross margin was -20.7%, and sales volume dropped to 126.7k MT. The Phase 5 build left Daqo with 305k MT of capacity just as industry supply outran buyers.
Today: Q1 2026 compressed the story to one test: sell above cost or stop selling. A recovery needs above-cost pricing and volume, not another headline about long-term solar growth.
Alignment helps, but minority holders still need a discount.
- Insiders own 36.1%. Directors and officers have real equity exposure, led by Guangfu Xu at 18.4% and Xiang Xu at 11.4%.
- Control stays in the family. Xiang Xu is chairman and CEO, Xiaoyu Xu is deputy CEO, and founder-family influence remains central.
- Committees are uneven. The audit committee is credible, but compensation and nominating oversight are not fully independent.
Lean long, but the next two quarters must earn it.
- For. At $19.22, Daqo trades below FY2025 cash per ADS of $28.84 and at 0.29x book with no financial debt.
- For. A re-rating only to 0.45x book gives $29.40 per ADS, below the 2019-2025 median P/B.
- Against. Q1 showed $98.4M of inventory impairment and -$147.5M operating cash flow, so book value is not a floor by itself.
- Against. Without enforceable above-cost pricing, management says it will lower utilization and sell closer to market.
Watchlist to re-rate: June-to-Q3 price-law enforcement; Q2/Q3 ASP versus total production cost; sales volume above 35k MT; operating cash flow turning positive.